Clinical use of plasma chitotriosidase in severe sepsis

Francesco Ardito, Felice Giuliante, Carlo Chiarla, Ivo Giovannini, Daniela Antuzzi, Andrea Piras

Risultato della ricerca: Contributo in rivistaArticolo in rivista

2 Citazioni (Scopus)

Abstract

Plasma chitotriosidase activity (ChT) was previously proposed to quantify severity of sepsis. In a complex surgical case, with prolonged sepsis and consistently high ChT, we found that the least increased values occurred in stages of extreme illness, with profound hypocholesterolemia. ChT needs better characterization before becoming a reliable biomarker of septic evolution.
Lingua originaleEnglish
pagine (da-a)273-276
Numero di pagine4
RivistaCurrent Medical Research and Opinion
Volume32
DOI
Stato di pubblicazionePubblicato - 2016

Keywords

  • Aged
  • Biomarkers
  • Critical illness
  • Hexosaminidases
  • Humans
  • Hypocholesterolemia
  • Intensive care
  • Male
  • Medicine (all)
  • Monitoring
  • Plasma chitotriosidase
  • Sepsis

Fingerprint

Entra nei temi di ricerca di 'Clinical use of plasma chitotriosidase in severe sepsis'. Insieme formano una fingerprint unica.

Cita questo